Showing results (861-870 of 906) with videos related to

Sort By:
Pageof 91
The Lancet. Psychiatry|January 23, 2022
Public mental health: required actions to address implementation failure in the context of COVID-19Jonathan Campion, Afzal Javed, Crick Lund, et al.
The Lancet. Psychiatry|April 8, 2022
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analysesDaniel Freeman, Sinéad Lambe, Thomas Kabir, et al.
The Lancet. Psychiatry|July 30, 2022
Prevalence of suicidal ideation and self-harm behaviours in children aged 12 years and younger: a systematic review and meta-analysisMarie-Claude Geoffroy, Samantha Bouchard, Megan Per, et al.
The Lancet. Psychiatry|May 5, 2023
Stressful life events and relapse of psychosis: analysis of causal association in a 2-year prospective observational cohort of individuals with first-episode psychosis in the UKSagnik Bhattacharyya, Tabea Schoeler, Marta Di Forti, et al.
The Lancet. Psychiatry|August 24, 2020
Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysisJose M Rubio, Georgios Schoretsanitis, Majnu John, et al.
The Lancet. Psychiatry|August 24, 2020
Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysisDan J Siskind, Brian T Wu, Tommy T Wong, et al.
The Lancet. Psychiatry|April 7, 2021
Motivation and methods of external organisations investing in mental health in low-income and middle-income countries: a qualitative studyValentina Iemmi
The Lancet. Psychiatry|April 16, 2021
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studiesTaishiro Kishimoto, Katsuhiko Hagi, Shunya Kurokawa, et al.
The Lancet. Psychiatry|November 13, 2025
Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trialsRichard S E Keefe, Philip D Harvey, Christoph U Correll, et al.
The Lancet. Psychiatry|November 13, 2025
Metformin for overweight and obese children and adolescents with bipolar spectrum and related mood disorders treated with second-generation antipsychotics: a randomised, pragmatic trialMelissa P DelBello, Jeffrey A Welge, Christina C Klein, et al.
Pageof 91